-
Quantum Hi-Tech and ECNU Establish AI-Driven Drug Manufacturing Lab
•
CRO+CDMO Quantum Hi-Tech (China) Biotechnology Co., Ltd (ChemPartner, SHE: 300149) announced plans to establish an AI drug intelligent manufacturing joint laboratory with East China Normal University (ECNU), a comprehensive research-oriented university in Shanghai. This collaboration aims to set a new paradigm for school-enterprise cooperation in the field of AI-driven pharmaceutical…
-
Quantum Hi-Tech (ChemPartner) Plans to Raise Over RMB 930 Million in Private Placement
•
Quantum Hi-Tech (China) Biotechnology Co., Ltd, known as ChemPartner (SHE: 300149), is poised to raise a significant amount of capital through a private share placement. The company plans to issue 149,389,197 shares at a price of RMB 6.23 per share, which is expected to yield over RMB 930 million (USD…
-
ChemPartner Pharmatech Enters Strategic Partnership with Malaysian Entities to Develop Innovative Drugs
•
ChemPartner Pharmatech Co., Ltd (SHE: 300149), a leading pharmaceutical company based in China, has joined hands with Universiti Kebangsaan Malaysia (UKM) and Pharma Medical Sdn Bhd (PMSB) from Malaysia to ink a strategic cooperation framework agreement aimed at developing innovative drugs. Financial specifics of the agreement have not been disclosed.…
-
Quantum Hi-Tech Partners with East China Normal University to Establish Advanced Drug Research Lab
•
Quantum Hi-Tech (China) Biotechnology Co., Ltd, known as ChemPartner (SHE: 300149), has entered into a strategic partnership with Shanghai’s East China Normal University (ECNU). The collaboration aims to establish a state-of-the-art joint laboratory dedicated to advancing research in drug discovery, biochips, drug delivery systems, and drug conjugates (XDCs). Furthermore, the…
